Identification of Individual Human Immunodeficiency Virus Type 1 Gp120 Amino Acids Important for CD4 Receptor Binding

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1990 Dec 1

PMID 2243375

Citations 218

Authors

U Olshevsky

E Helseth

C Furman

J Li

W Haseltine

J Sodroski

Affiliations

Soon will be listed here.

Abstract

The binding of the CD4 receptor by the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein is important for virus entry and cytopathic effect. To investigate the CD4-binding region of the gp120 glycoprotein, we altered gp120 amino acids, excluding cysteines, that are conserved among the primate immunodeficiency viruses utilizing the CD4 receptor. Changes in two hydrophobic regions (Thr-257 in conserved region 2 and Trp-427 in conserved region 4) and two hydrophilic regions (Asp-368 and Glu-370 in conserved region 3 and Asp-457 in conserved region 4) resulted in significant reductions in CD4 binding. For most of the mutations affecting these residues, the observed effects on CD4 binding did not apparently result from global conformational disruption of the gp120 molecule, as assessed by measurements of precursor processing, subunit association, and monoclonal antibody recognition. The two hydrophilic regions exhibit a strong propensity for beta-turn formation, are predicted to act as efficient B-cell epitopes, and are located adjacent to hypervariable, glycosylated regions. This study defines a small number of gp120 residues important for CD4 binding, some of which might constitute attractive targets for immunologic intervention.

Citing Articles

Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.

Ding H, Nguyen H, Li W, Deshpande A, Zhang S, Jiang F J Virol. 2024; 98(12):e0172024.

PMID: 39508605 PMC: 11650979. DOI: 10.1128/jvi.01720-24.

Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.

Dam K, Fan C, Yang Z, Bjorkman P Nature. 2023; 623(7989):1017-1025.

PMID: 37993719 PMC: 10686819. DOI: 10.1038/s41586-023-06639-8.

Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry.

Ugwu-Korie N, Quaye O, Wright E, Languon S, Agyapong O, Broni E Molecules. 2023; 28(2).

PMID: 36677538 PMC: 9865492. DOI: 10.3390/molecules28020474.

Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines.

Chaplain C, Fritschi C, Anang S, Gong Z, Richard J, Bourassa C ACS Med Chem Lett. 2023; 14(1):51-58.

PMID: 36655122 PMC: 9841591. DOI: 10.1021/acsmedchemlett.2c00376.

Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities.

Timofeeva A, Sedykh S, Nevinsky G Vaccines (Basel). 2022; 10(3).

PMID: 35335016 PMC: 8955465. DOI: 10.3390/vaccines10030384.

References

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

Leonard C, Spellman M, Riddle L, Harris R, Thomas J, Gregory T . Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem. 1990; 265(18):10373-82. View

Popovic M, Sarngadharan M, Read E, Gallo R . Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984; 224(4648):497-500. DOI: 10.1126/science.6200935. View

Gallo R, Salahuddin S, Popovic M, Shearer G, Kaplan M, Haynes B . Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984; 224(4648):500-3. DOI: 10.1126/science.6200936. View

Klatzmann D, Barre-Sinoussi F, Nugeyre M, Danquet C, Vilmer E, Griscelli C . Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science. 1984; 225(4657):59-63. DOI: 10.1126/science.6328660. View

Dalgleish A, Beverley P, Clapham P, Crawford D, Greaves M, Weiss R . The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984; 312(5996):763-7. DOI: 10.1038/312763a0. View

Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T . T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984; 312(5996):767-8. DOI: 10.1038/312767a0. View

Robey W, Safai B, Oroszlan S, Arthur L, Gonda M, Gallo R . Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science. 1985; 228(4699):593-5. DOI: 10.1126/science.2984774. View

Allan J, Coligan J, Barin F, McLane M, Sodroski J, Rosen C . Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science. 1985; 228(4703):1091-4. DOI: 10.1126/science.2986290. View

10.

Lane H, Depper J, Greene W, Whalen G, Waldmann T, Fauci A . Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985; 313(2):79-84. DOI: 10.1056/NEJM198507113130204. View

11.

McDougal J, Kennedy M, Sligh J, Cort S, Mawle A, Nicholson J . Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science. 1986; 231(4736):382-5. DOI: 10.1126/science.3001934. View

12.

Gottlieb M . Immunologic aspects of the acquired immunodeficiency syndrome and male homosexuality. Med Clin North Am. 1986; 70(3):651-64. DOI: 10.1016/s0025-7125(16)30944-0. View

13.

Modrow S, Hahn B, Shaw G, Gallo R, Wong-Staal F, Wolf H . Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol. 1987; 61(2):570-8. PMC: 253982. DOI: 10.1128/JVI.61.2.570-578.1987. View

14.

Stein B, Gowda S, Lifson J, Penhallow R, Bensch K, Engleman E . pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 1987; 49(5):659-68. DOI: 10.1016/0092-8674(87)90542-3. View

15.

Lasky L, Nakamura G, Smith D, Fennie C, Shimasaki C, Patzer E . Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987; 50(6):975-85. DOI: 10.1016/0092-8674(87)90524-1. View

16.

Kowalski M, Potz J, Basiripour L, Dorfman T, Goh W, Terwilliger E . Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 1987; 237(4820):1351-5. DOI: 10.1126/science.3629244. View

17.

Cullen B . Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 1987; 152:684-704. DOI: 10.1016/0076-6879(87)52074-2. View

18.

Kunkel T, Roberts J, Zakour R . Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987; 154:367-82. DOI: 10.1016/0076-6879(87)54085-x. View

19.

Jameson B, Rao P, Kong L, Hahn B, Shaw G, HOOD L . Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science. 1988; 240(4857):1335-9. DOI: 10.1126/science.2453925. View

20.

Peterson A, Seed B . Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell. 1988; 54(1):65-72. DOI: 10.1016/0092-8674(88)90180-8. View